Picture of Novacyt SA logo

NCYT Novacyt SA Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Novacyt SA, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

R2019
December 31st
2020
December 31st
C2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5.75132-9.73-25.7-28.3
Depreciation
Non-Cash Items254.8-0.2132.42-0.965
Unusual Items
Other Non-Cash Items
Changes in Working Capital1.22-92.517.71.66-5.38
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.94110315.7-13.7-25
Capital Expenditures-0.204-1.18-4.1-0.416-0.671
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.843-6.78-0.887-0.161-13.3
Acquisition of Business
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities-1.05-7.96-4.99-0.577-13.9
Financing Cash Flow Items-0.334-2.81-0.455
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2.5-5.04-0.639-0.516-3.97
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.52190.29.98-14.8-42.9